- Home
- Publications
- Publication Search
- Publication Details
Title
Unleashing the immune response against childhood solid cancers
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 64, Issue 10, Pages e26548
Publisher
Wiley
Online
2017-04-07
DOI
10.1002/pbc.26548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
- (2016) Paolo Anderlini et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells
- (2016) David F. Stroncek et al. CYTOTHERAPY
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
- (2016) Gregory L. Beatty et al. PHARMACOLOGY & THERAPEUTICS
- Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells
- (2016) Ravikumar Muthuswamy et al. PROSTATE
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?
- (2016) Armin Rashidi et al. Expert Review of Hematology
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
- (2016) Luuk van Hooren et al. Oncotarget
- Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin
- (2016) Junmin Zhou et al. Scientific Reports
- Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
- (2016) A. H. Long et al. Cancer Immunology Research
- Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma
- (2015) Aurelie Guislain et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity
- (2015) F. Mussai et al. CANCER RESEARCH
- Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) J. A. Califano et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
- (2015) H.-M. Chen et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Chimeric antigen receptor T cells for ALL
- (2015) Persis J Amrolia et al. LANCET
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing
- (2015) Annick Mühlethaler-Mottet et al. PLoS One
- The odds of immunotherapy success
- (2015) M. M. Gubin et al. SCIENCE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma
- (2015) Siwen Hu-Lieskovan et al. Science Translational Medicine
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
- (2015) Laura Pinton et al. Oncotarget
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
- (2015) Svetlana Karakhanova et al. OncoImmunology
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
- (2015) Oana Draghiciu et al. OncoImmunology
- Armed antibodies for cancer treatment: a promising tool in a changing era
- (2014) Riccardo Danielli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1-PD-L1 Axis
- (2014) Z.-C. Ding et al. CANCER RESEARCH
- Gangliosides Drive the Tumor Infiltration and Function of Myeloid-Derived Suppressor Cells
- (2014) A. Wondimu et al. CANCER RESEARCH
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF- 1
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Immune-based therapies for childhood cancer
- (2014) Crystal L. Mackall et al. Nature Reviews Clinical Oncology
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
- (2014) Ahmad A. Tarhini et al. PLoS One
- Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation
- (2014) Zhi-Chun Ding et al. OncoImmunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract
- (2013) Pratima Sinha et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Melanoma-Educated CD14 + Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
- (2013) Yumeng Mao et al. CANCER RESEARCH
- Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells
- (2013) G. Santilli et al. CLINICAL CANCER RESEARCH
- The immune environment of paediatric solid malignancies: evidence from an immunohistochemical study of clinical cases
- (2013) John R. Apps et al. Fetal and Pediatric Pathology
- Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
- (2013) Michael C. Jensen et al. IMMUNOLOGICAL REVIEWS
- Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells
- (2013) Jilin Ma et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1
- (2013) Manisha Singh et al. Cancer Medicine
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Catechins and antitumor immunity
- (2013) Giorgia Santilli et al. OncoImmunology
- Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
- (2013) Yana G. Najjar et al. Frontiers in Oncology
- PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
- (2012) Nataša Obermajer et al. IMMUNOLOGICAL INVESTIGATIONS
- IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
- (2012) Daofeng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 Tumors
- (2012) Romana Mikyšková et al. JOURNAL OF IMMUNOTHERAPY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
- (2012) Agnes Rasmuson et al. PLoS One
- Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines
- (2012) Matthew A. Bill et al. PLoS One
- Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
- (2012) Julie Liberman et al. PLoS One
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Hyperbaric oxygen therapy and cancer—a review
- (2012) Ingrid Moen et al. Targeted Oncology
- Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers
- (2012) Rimas J. Orentas et al. Frontiers in Oncology
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
- (2011) S. P. Tu et al. Cancer Prevention Research
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preliminary experience with personalized and targeted therapy for pediatric brain tumors
- (2011) Johannes E. Wolff et al. PEDIATRIC BLOOD & CANCER
- COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
- (2010) Joris D Veltman et al. BMC CANCER
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function
- (2010) Moshe Elkabets et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunomodulatory Effects ofWithania Somniferaon Azoxymethane Induced Experimental Colon Cancer in Mice
- (2010) Govidan Muralikrishnan et al. IMMUNOLOGICAL INVESTIGATIONS
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
- (2010) Matthew A Bill et al. Molecular Cancer
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
- (2009) Hanh K. Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
- (2008) T. Ara et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started